3.2 Exposure Routes & Human Health Hazards

3.2 Exposure Routes & Human Health Hazards

Executive Summary: Understanding how pesticides enter the human body and interact with physiological systems is essential for preventing occupational poisoning. Pesticides enter the body through four primary exposure pathways: dermal (skin), inhalation (lungs), oral (ingestion), and ocular (eyes). The severity of a toxic reaction depends on the exposure pathway, chemical formulation, exposure duration, absorption rate, and total absorbed dose. Organophosphate and carbamate insecticides represent significant human hazards due to their ability to inhibit acetylcholinesterase, an essential enzyme regulating nerve impulse transmission.

---

The Four Primary Pathways of Exposure

1. Dermal Exposure (Skin Contact)

Dermal contact is by far the most common pathway of occupational exposure in agricultural, turf, and structural pest management, accounting for approximately 90% of all applicator exposure incidents. Dermal contact occurs during mixing concentrate, handling contaminated spray hoses, clearing clogged nozzles, adjusting spray booms, or contacting treated foliage.

Dermal absorption rates vary dramatically across different anatomical sites due to variations in skin thickness, vascularization, pore density, and stratum corneum permeability. The table below illustrates relative dermal absorption rates compared to the forearm baseline (1.0x):

FACTORS ACCELERATING DERMAL ABSORPTION: Warm skin temperatures, active perspiration, open cuts or abrasions, and liquid emulsifiable concentrate (EC) formulations containing petroleum solvents significantly increase chemical penetration across all anatomical sites.

2. Inhalation Exposure (Lungs)

Inhalation exposure occurs when applicators breathe in airborne particles, fine mists, smoke, dusts, or volatile vapors. Inhalation presents an extreme hazard because the human respiratory system contains over 300 million alveoli with a total surface area exceeding 70 square meters.

Pesticides absorbed through alveolar membranes pass directly into pulmonary capillary blood, bypassing the liver's first-pass metabolic detoxification pathways. Volatile fumigants, ultra-low-volume (ULV) fogs, fine mists, and dry powders present severe inhalation hazards, particularly in enclosed environments such as greenhouses, grain silos, or crawl spaces.

3. Oral Exposure (Ingestion)

Oral exposure occurs when pesticides enter the gastrointestinal tract through the mouth. Although less frequent than dermal exposure, oral ingestion carries an extremely high risk of severe systemic poisoning or death. Primary causes of accidental ingestion include:

• Transferring chemical concentrates into unlabeled food or beverage containers (e.g., soda bottles).
• Eating, drinking, or using tobacco products with contaminated hands.
• Clearing clogged spray nozzles by blowing through them with the mouth.
• Rubbing the face or lips with contaminated gloves.

4. Ocular Exposure (Eyes)

The eyes consist of highly permeable, vascularized tissue. Pesticide contact with the eyes can cause localized damage—such as conjunctivitis, corneal clouding, or permanent blindness—as well as rapid systemic absorption directly into orbital blood vessels. Splashes while pouring liquid concentrates or blowing dusts present major ocular hazards.

---

Insecticide Mode of Action: Cholinesterase Inhibition

Different pesticide classes target specific physiological systems. Among insecticides, organophosphates (e.g., chlorpyrifos, malathion, diazinon) and carbamates (e.g., carbaryl, methomyl) present severe human toxicological hazards due to a shared mode of action: cholinesterase inhibition.

Mechanism of Nerve Impairment

1. Normal Neural Function: Electrical impulses travel along nerve fibers to synapses. The neurotransmitter acetylcholine (ACh) is released into the synaptic cleft to transmit the impulse to adjacent nerve cells, muscle fibers, or glands. Once transmitted, the enzyme acetylcholinesterase (AChE) immediately breaks down acetylcholine into choline and acetic acid, allowing the muscle or gland to relax.
2. Enzyme Inhibition: Organophosphate and carbamate chemicals bind to acetylcholinesterase, preventing the enzyme from degrading acetylcholine.
3. Hyperstimulation: Acetylcholine accumulates in synaptic clefts, causing continuous, uncontrolled firing of the nervous system. This results in severe muscle spasms, excessive glandular secretions, and respiratory distress.

[Normal Synapse]   ACh Released ---> Transmits Impulse ---> AChE Cleaves ACh ---> Muscle Relaxes
[Inhibited Synapse] OP/Carbamate ---> Inhibits AChE    ---> ACh Accumulates ---> Continuous Spasms/Seizures

Organophosphates vs. Carbamates

While both chemical families inhibit AChE, organophosphates form a permanent covalent bond with the enzyme over time (a process known as "aging"), making biological recovery dependent on synthesizing new enzyme proteins unless treated early with pralidoxime (2-PAM). Carbamates form a reversible bond that slowly hydrolyzes, allowing enzyme activity to recover spontaneously within hours.

---

Clinical Progression of Acute Poisoning Symptoms

Recognizing the symptoms of cholinesterase inhibition can save an applicator's life. Symptoms progress through three distinct severity stages based on absorbed dose:

DIAGNOSTIC MARKER: Pinpoint pupils (miosis) combined with excessive salivation and muscle twitching are key diagnostic markers distinguishing cholinesterase inhibitor poisoning from heat illness.

---

Medical Surveillance: Cholinesterase Testing

Applicators who regularly handle Toxicity Category I or II organophosphate or carbamate pesticides should participate in a professional cholinesterase medical surveillance program.

Baseline Testing Protocol

Before the spraying season begins, applicators must establish their personal pre-exposure baseline cholinesterase level:

• Baseline testing requires two separate blood samples taken at least 3 to 14 days apart.
• Blood samples must be drawn when the applicator has had no exposure to organophosphates or carbamates for at least 30 consecutive days.

Red Blood Cell vs. Plasma Cholinesterase

Cholinesterase monitoring evaluates two distinct blood components:

• Red Blood Cell (RBC) Cholinesterase: True acetylcholinesterase found on red blood cell membranes. Reflects enzyme levels in nervous tissue and recovers slowly (roughly 1% per day).
• Plasma (Pseudo) Cholinesterase: Produced in the liver. Highly sensitive to chemical exposure but recovers rapidly.

Medical Action Thresholds

Comparing periodic active-season blood tests against the pre-season baseline determines medical management:

• 20% to 30% Depression: Indicates significant chemical exposure. The employer should review handling practices, PPE integrity, and equipment maintenance.
• 40% to 50% Depression Below Baseline: Requires IMMEDIATE MEDICAL REMOVAL of the applicator from all handling activities involving organophosphates and carbamates until enzyme levels recover to within 20% of baseline.